# Thorough Images

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thorough-images

- Industry: Healthcare IT
- Headquarters: Beijing, China
- Website: www.thorough.ai
- Total disclosed funding: $28M
- Latest round: Series A (Sep 26, 2025)
- Investors on record: 6

## About

Based in Beijing, China, and established in 2017, Thorough Images, Inc. is a healthcare technology company that develops imaging diagnosis software based on AI and big data technology. The company has cooperated with the General Hospital of the Chinese People's Liberation Army, Google, Intel, etc. It acquired a Class II medical device registration certificate for diagnostic pathology image processing software in April 2023. In September 2025, Thorough Images, Inc. raised a series A++ funding from returning investor BridgeOne Capital.
The company is committed to using big data and artificial intelligence to provide intelligent differentiation, diagnosis, and prediction of pathology images and to provide users with solutions related to image diagnosis. The main products are Thorough Insights, Thorough ESD, Thorough Cure, and Thorough Eye. Thorough Insights is a smart pathology diagnostic platform that can be applied to tumor-prone organs, including the stomach, intestines, esophagus, and so on, and it also can automate the staging of malignant tumors and the identification of benign lesions. The company generates revenue by providing pathology diagnostic platforms and solutions. The funds raised from this Series A++ round will be primarily used to further promote the clinical application and promotion of comprehensive brain pathology models and accelerate the global deployment of digital pathology.

## Funding rounds

- Series A, Sep 26, 2025 — BridgeOne Capital
- Series A, Jun 6, 2024, $14M — Bioching Capital, Zhongke Angel Fund
- Series A, Jun 26, 2023, $14M — Qiming Venture Partners, Korea Investment Partners
- Angel, Aug 29, 2018 — Hongdao Capital

## Investors

- Hongdao Capital (https://capitalatlas.ai/funds/hongdao-capital) — Angel
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A
- Bioching Capital (https://capitalatlas.ai/funds/bioching-capital) — Series A
- Zhongke Angel Fund (https://capitalatlas.ai/funds/zhongke-angel-fund) — Series A
- BridgeOne Capital (https://capitalatlas.ai/funds/bridgeone-capital) — Series A